Stage I Childhood Hodgkin Lymphoma: Clinical Trials

7 trials for Stage I Childhood Hodgkin Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 2 Not applicable, 2 Phase 2, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 22Completed 2
Phase 32Completed 2
Early Phase 11Completed 1

Follow Stage I Childhood Hodgkin Lymphoma: new trials by email Literature Review of Stage I Childhood Hodgkin Lymphoma trials Research Report on Stage I Childhood Hodgkin Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
busulfan, etoposide, cyclophosphamide - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Early Phase 1CompletedCase Comprehensive Cancer Center332014-03-012015-08-13
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
massage therapy, questionnaire administration, quality-of-life assessment - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedWake Forest University Health Sciences802010-04-012018-07-02
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2CompletedFred Hutchinson Cancer Center1402007-04-012021-02-03
Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
ifosfamide, bortezomib, vinorelbine tartrate - Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)262007-01-012021-03-24
Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
radiation therapy, doxorubicin hydrochloride, vincristine sulfate - Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma
Phase 3CompletedChildren's Oncology Group2872006-02-012021-03-30
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
Bleomycin Sulfate, Cisplatin, Cyclophosphamide - Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma, Childhood Mixed Cellularity Classical Hodgkin Lymphoma
Phase 3CompletedChildren's Oncology Group17342002-09-012017-04-12
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedFred Hutchinson Cancer Center51999-11-012017-05-24

Narrower conditions

Hodgkin Disease (6)  ·  Burkitt Lymphoma (4)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (4)  ·  Lymphoma, Large B-Cell, Diffuse (4)  ·  Lymphoma, T-Cell, Cutaneous (4)  ·  Mycosis Fungoides (4)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Recurrence (4)  ·  Sezary Syndrome (4)  ·  Blast Crisis (3)  ·  Dendritic Cell Sarcoma, Interdigitating (3)  ·  Immunoblastic Lymphadenopathy (3)  ·  Intraocular Lymphoma (3)  ·  Leukemia, Hairy Cell (3)  ·  Leukemia, Large Granular Lymphocytic (3)

Broader conditions

Hemic and Lymphatic Diseases (7)  ·  Immune System Diseases (7)  ·  Immunoproliferative Disorders (7)  ·  Lymphatic Diseases (7)  ·  Lymphoproliferative Disorders (7)  ·  Neoplasms (7)  ·  Neoplasms by Histologic Type (7)  ·  Lymphoma (6)  ·  Disease Attributes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Blood Protein Disorders (4)  ·  Cardiovascular Diseases (4)  ·  Chronic Disease (4)  ·  DNA Virus Infections (4)

Interventions

Cyclophosphamide (3)  ·  Filgrastim (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Calcium Dobesilate (2)  ·  Cisplatin (2)  ·  Cytarabine (2)  ·  Dexamethasone (2)  ·  Doxorubicin (2)  ·  Etoposide (2)  ·  Ifosfamide (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Prednisone (2)  ·  Vincristine (2)  ·  Vinorelbine (2)  ·  indolepropanol phosphate (2)

Sponsors

Children's Oncology Group (2)  ·  Fred Hutchinson Cancer Center (2)  ·  Case Comprehensive Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (7)  ·  Australia (1)  ·  Canada (1)  ·  Israel (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  Switzerland (1)

Top investigators

Ann Woolfrey (1)  ·  Brian Hill, MD (1)  ·  Debra Friedman (1)  ·  Frank Keller, MD (1)  ·  Janet Tooze, PhD (1)  ·  Paul Martin (1)  ·  Terzah Horton (1)

Results publications

PMID 37505794, PMID 18698002, PMID 25311218, PMID 25833390, PMID 29296710, PMID 33512412, PMID 34662378, PMID 35763667, PMID 40135712

NIH funding

U10CA098543 (3), P01CA018029 (1), P30CA015704 (1), P30CA043703 (1)